AU2003217174A8 - Novel variants of rankl protein - Google Patents

Novel variants of rankl protein

Info

Publication number
AU2003217174A8
AU2003217174A8 AU2003217174A AU2003217174A AU2003217174A8 AU 2003217174 A8 AU2003217174 A8 AU 2003217174A8 AU 2003217174 A AU2003217174 A AU 2003217174A AU 2003217174 A AU2003217174 A AU 2003217174A AU 2003217174 A8 AU2003217174 A8 AU 2003217174A8
Authority
AU
Australia
Prior art keywords
novel variants
rankl protein
rankl
protein
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217174A
Other versions
AU2003217174A1 (en
Inventor
John R Desjarlais
Shannon Alicia Marshall
Rene S Hubert
Jamal El Yazal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xencor Inc
Original Assignee
Xencor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xencor Inc filed Critical Xencor Inc
Publication of AU2003217174A1 publication Critical patent/AU2003217174A1/en
Publication of AU2003217174A8 publication Critical patent/AU2003217174A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
AU2003217174A 2002-01-04 2003-01-06 Novel variants of rankl protein Abandoned AU2003217174A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US34580502P 2002-01-04 2002-01-04
US60/345,805 2002-01-04
US37345302P 2002-04-17 2002-04-17
US60/373,453 2002-04-17
US37403502P 2002-04-19 2002-04-19
US60/374,035 2002-04-19
PCT/US2003/000393 WO2003059281A2 (en) 2002-01-04 2003-01-06 Novel variants of rankl protein

Publications (2)

Publication Number Publication Date
AU2003217174A1 AU2003217174A1 (en) 2003-07-30
AU2003217174A8 true AU2003217174A8 (en) 2003-07-30

Family

ID=32096834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217174A Abandoned AU2003217174A1 (en) 2002-01-04 2003-01-06 Novel variants of rankl protein

Country Status (3)

Country Link
EP (1) EP1560843A4 (en)
AU (1) AU2003217174A1 (en)
WO (1) WO2003059281A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003207464A1 (en) 2002-01-04 2003-07-24 Xencor Dominant negative proteins and methods thereof
US7381792B2 (en) 2002-01-04 2008-06-03 Xencor, Inc. Variants of RANKL protein
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
DE102004014983A1 (en) * 2004-03-26 2005-10-20 Univ Stuttgart Recombinant polypeptides of the members of the TNF ligand family and their use
WO2005113598A2 (en) * 2004-05-21 2005-12-01 Xencor, Inc. Tnf super family members with altered immunogenicity
CN104059141B (en) * 2014-04-14 2017-09-12 江苏省原子医学研究所 A kind of structure of mouse RANKL mutant and its expression vector, expression and application
US9914761B2 (en) 2014-07-10 2018-03-13 Washington University Oligomers for TNF superfamily inhibition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2274987C (en) * 1996-12-23 2012-01-24 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
PL196790B1 (en) * 1998-09-15 2008-01-31 Pharmexa As Application of animal OPGL polypeptide or its subsequence, or the OPGL analogue, use of fragment of nucleic acid, use of the vector transmitting fragment of nucleic acid, use of non-pathogenic transformed cell, application of a compound containing such fr
US7300774B1 (en) * 1999-12-09 2007-11-27 The Regents Of The University Of California Multimeric fusion proteins of the TNF superfamily ligands
AR025984A1 (en) * 1999-10-07 2002-12-26 Maxygen Aps SIMPLE CHAIN OLIGOMERIC POLYPEPTIDES
JP2003525612A (en) * 2000-03-02 2003-09-02 ゼンコー Design and discovery of variant TNF-α proteins for treatment of TNF-α related disorders

Also Published As

Publication number Publication date
EP1560843A2 (en) 2005-08-10
WO2003059281A3 (en) 2005-06-02
EP1560843A4 (en) 2006-09-06
WO2003059281A2 (en) 2003-07-24
AU2003217174A1 (en) 2003-07-30
WO2003059281A9 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
IL262513A (en) Protein purification
EP1578774A4 (en) Protein purification
AU2003217174A8 (en) Novel variants of rankl protein
AU2003282338A8 (en) Determination of protein function
AU2003254001A8 (en) Novel htnfsf13b protein variants
GB0201808D0 (en) Protein
PL376318A1 (en) Protein modification
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0206684D0 (en) Novel proteins
AU2003232176A8 (en) Protein c variants with altered properties
GB0220038D0 (en) Novel Protein Design
GB0202748D0 (en) Protein
GB0204735D0 (en) Protein
GB0214703D0 (en) Novel protein
GB0216601D0 (en) Modified protein
GB0207141D0 (en) Modified protein
GB0306466D0 (en) Novel protein
GB0203156D0 (en) Protein
GB0205264D0 (en) Protein
GB0205266D0 (en) Protein
GB0205268D0 (en) Protein
GB0203159D0 (en) Protein
GB0203165D0 (en) Protein
GB0205019D0 (en) Protein
GB0203158D0 (en) Protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase